Antioxidant status in beta thalassemia major: A single-center study

Indian Journal of Pathology and Microbiology

Volumn 54, Issue 4, 2011, Pages 761-763

  Waseem, Faiza ^a   Khemomal, Karira A ^b   Sajid, Raihan ^c  

^a Liaquat College of Medicine and Dentistry   (Pakistan)

^b JINNAH POSTGRADUATE MEDICAL CENTRE   (Pakistan)

^c AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

Glutathione peroxidase; oxidative stress; superoxide dismutase; thalassemia major

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; FERRITIN; GLUTATHIONE PEROXIDASE; HEMOGLOBIN; IRON; SUPEROXIDE DISMUTASE;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD TRANSFUSION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; FERRITIN BLOOD LEVEL; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFANT; IRON OVERLOAD; LIVER CELL DAMAGE; MALE; PRESCHOOL CHILD; SCHOOL CHILD; THALASSEMIA MAJOR; VITAMIN BLOOD LEVEL;

ADOLESCENT; ANTIOXIDANTS; BETA-THALASSEMIA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; INFANT; MALE; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; VITAMIN E; YOUNG ADULT;

EID: 84856365960     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.91489     Document Type: Article

References (15)

1. Ahmed S, Saleem M, Modell B, Petrou M. Screening extended families for genetic hemoglobin disorders in Pakistan. N Engl J Med 2002;347:1162-8.
2. Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood 1997;89:739-61. (Pubitemid 27121266)
3. Reller K, Dresow B, Collell M, Fischer R, Engelhardt R, Nielsen P, et al. Iron overload and antioxidant status in patients with β-thalassemia major. Ann N Y Acad Sci 1998;850:463-5. (Pubitemid 28369805)
4. Kattamis C, Kattamis AC. Oxidative stress disturbances in erythrocytes of β-thalassemia. Pediatr Hematol Oncol 2000;8:85-8.
5. Chakraborty D, Bhattacharyya M. Oxidant defense status of red blood cells of patients with β-thalassemia and E β thalassemia. Clin Chim Acta 2001;305:123-9. (Pubitemid 32201969)
6. Walter PB, Fung EB, Killilea DW, Jiang Q, Hudes M, Madden J, et al. Oxidative stress and inflammation in iron-overloaded patients with β-thalassemia or sickle cell disease. Br J Haematol 2006;135:254-63. (Pubitemid 44401624)
7. Traber MG, Packer L. Vitamin E: Function beyond antioxidant. Am J Clin Nutr 1995;62:1501S-9S.
8. Filosa A, Valgimigli L, Pedulli GF, Sapone A, Maggio A, Renda D, et al. Quantitative evaluation of oxidative stress status on peripheral blood in β-thalassemic patients by means of electron paramagnetic resonance spectroscopy. Br J Hematol 2005;131:135-40. (Pubitemid 43899719)
9. Scott MD, Repka T, Hebbel RP, van den Berg JM, Wagner TC, Lubin BH et al. Membrane deposition of heme and non-heme iron in model thalassemic erythrocytes. Blood 1991;78:771.
10. Dhawan V, Kumar KhR, Marwaha RK, Ganguly NK. Antioxidant status in children with homozygous thalassemia. Indian Pediatr 2005;42:1141-5. (Pubitemid 43373140)
11. Simsek, Ozturk G, Kemahli S, Erbas D, Hasanoglu A. A Oxidant and antioxidant status in β thalassemia major patients. J Ankara Univ Fac Med 2005;58:34-8.
12. Gerli GC, Beretta L, Bianchi M, Pellegatta A, Agostoni A. Erythrocyte superoxide dismutase, catalase and glutathione peroxidase activities in β-thalassemia (major and minor). Scand J Haematol 1980;25:87-92. (Pubitemid 10046731)
13. Garelnabi M, Paradhan P. Splenectomy may not influence glutathione metabolism in children with β thalassemia major. Turk J Haematol 2005;22:25-30. (Pubitemid 40520752)
14. Nasr MR, Ali S, Shaker M and Elgabry E. Antioxidant micronutrient in children with thalassemia in Egypt. East Mediterr Health J 2002;8:1-5.
15. Laksmitawati DR, Handayani S, Udyaningsih-Freisleben SK, Kurniati V, Adhiyanto C, Hidayat J, et al. Iron status and oxidative stress in β-thalassemia patients in Jakarta. Biofactors 2003;19:53-62. (Pubitemid 38073144)